Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Breo Ellipta for Treatment of Chronic Obstructive Pulmonary Disease (COPD)

Drug Name (Brand / Generic)

Breo Ellipta / fluticasone furoate and vilanterol inhalation powder

Company / Licensee

GlaxoSmithKline (GSK) / Theravance

Product Description

Combination of inhaled corticosteroid (ICS) and long-acting beta2 agonist (LABA)

Current Indication

Chronic obstructive pulmonary disease (COPD)

Market Sector

Respiratory

Development Status

Approved in the US, Japan and Canada
Expand
Close
Close
Close

Go Top